Nutrien (NTR) Stock Forecast & Price Target

Q: What analysts cover Nutrien?

Nutrien has been rated by research analysts at Barclays , BNP Paribas Exane , Canadian Imperial Bank of Commerce , KeyCorp , Mizuho , Morgan Stanley , National Bank Financial , Oppenheimer , Royal Bank Of Canada , Scotia , Scotiabank , and Weiss Ratings in the past 90 days.

$77.12 -1.80 (-2.28%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$77.10 -0.02 (-0.02%)

As of 09/18/2026 07:30 PM Eastern

Compare

Nutrien - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
1

Hold
4

Buy
17

Based on 22 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 4 have given a hold rating, and 17 have given a buy rating for NTR.

Consensus Price Target

$81.15
5.23% Upside

According to the 22 analysts' twelve-month price targets for Nutrien, the average price target is $81.15. The highest price target for NTR is $100.00, while the lowest price target for NTR is $65.00. The average price target represents a forecasted upside of 5.23% from the current price of $77.12.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTR Analyst Ratings Over Time

Type	Current Forecast 9/19/25 to 9/19/26	1 Month Ago 8/20/25 to 8/20/26	3 Months Ago 6/21/25 to 6/21/26	1 Year Ago 9/19/24 to 9/19/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	17 Buy rating(s)	17 Buy rating(s)	11 Buy rating(s)	6 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	8 Hold rating(s)	11 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$81.15	$81.58	$81.71	$62.39
Forecasted Upside	5.23% Upside	11.46% Upside	29.91% Upside	10.27% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nutrien Stock vs. The Competition

Type	Nutrien	Materials Companies	Broader Market
Consensus Rating Score	2.73	2.57	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	5.23% Upside	137.01% Upside	18.44% Upside
News Sentiment Rating	Positive News See Recent NTR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/18/2026	Royal Bank Of Canada 3 of 5 stars	Andrew D. Wong Not Rated	Reiterated Rating	Outperform	$85.00	+9.76%
9/10/2026	KeyCorp 2 of 5 stars	Salvator Tiano Not Rated	Initiated Coverage	Sector Weight	$73.00	-7.36%
8/10/2026	Canadian Imperial Bank of Commerce 3 of 5 stars	Hamir Patel 1 of 5 stars	Reiterated Rating	Outperform
8/10/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$81.00 ➝ $78.00	+21.13%
8/10/2026	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$76.00 ➝ $74.00	+12.33%
8/6/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C+) ➝ Buy (B-)
7/28/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$80.00	+18.59%
7/23/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Owen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$82.00 ➝ $80.00	+16.36%
7/14/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edlain Rodriguez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$77.00 ➝ $75.00	+10.87%
7/7/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Sinisi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$93.00 ➝ $81.00	+23.30%
Get the Latest News and Ratings for NTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.
6/30/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Isaacson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$80.00	+30.62%
6/30/2026	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sector Perform ➝ Sector Outperform	$80.00	+25.96%
6/10/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucy Bi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy ➝ Hold	$65.00	-1.94%
5/11/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Beaumont Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sell	$67.00 ➝ $65.00	-8.88%
5/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$78.00 ➝ $80.00	+12.15%
5/6/2026	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
5/5/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$74.00 ➝ $90.00	+16.83%
4/30/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew DeYoe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$82.00	+10.63%
3/18/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joel Jackson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$85.00 ➝ $90.00	+15.51%
3/13/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$77.00 ➝ $100.00	+19.28%
3/12/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$74.00 ➝ $96.00	+21.11%
3/2/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
5/9/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Duffy Fischer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sell	$53.00 ➝ $59.00	+6.75%
1/27/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Neivert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$58.00 ➝ $63.00	+18.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:00 PM ET.

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 14, 2026. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

Nutrien Ltd. recently reported strong financial performance in its latest quarterly results, with revenue of $10.81 billion, which exceeded the analyst consensus estimate of $10.44 billion. This indicates that the company is successfully driving top-line growth, with revenue up 3.6% on a year-over-year basis, suggesting robust demand for its crop inputs and agricultural services.
The company offers a stable income stream for investors through its dividend policy, currently paying a quarterly dividend of $0.55 per share. This translates to an annualized dividend yield of 2.80%, which is attractive for income-focused investors, especially given that the dividend payout ratio is a manageable 44.53% of earnings, leaving room for future growth or buybacks.
Nutrien Ltd. is trading at a current stock price of $76.95, which is below the consensus price target of $81.15 set by seventeen analysts who have rated the stock with a Buy rating. This suggests that the stock may be undervalued relative to its fundamental worth, offering potential upside for investors who believe in the company's long-term trajectory.
The company has a relatively low beta of 0.62, which means its stock price tends to be less volatile than the overall market. This characteristic can be beneficial for investors looking to reduce portfolio risk, as Nutrien Ltd. may provide more stable returns during periods of market turbulence.
Nutrien Ltd. has a strong balance sheet, with a debt-to-equity ratio of 0.36, indicating that the company is not overly leveraged. This financial stability provides a cushion against economic downturns and allows the company to invest in growth opportunities without taking on excessive debt.

Nutrien
Bear Case

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

Despite strong revenue, Nutrien Ltd. missed its earnings per share (EPS) expectations in its latest quarterly report, posting $2.61 per share compared to the consensus estimate of $2.70. This miss could signal that the company is facing margin pressures or higher-than-expected costs, which may impact future profitability.
The stock has experienced a recent decline, with the current price of $76.95 down from the previous close of $78.45. This short-term downward momentum could indicate that investors are losing confidence in the company's near-term prospects, potentially leading to further price declines.
Nutrien Ltd. is operating in the Fertilizers & Agricultural Chemicals industry, which is subject to significant commodity price volatility. Fluctuations in the prices of key inputs like potash, nitrogen, and phosphate can directly impact the company's profit margins, making its earnings less predictable.
The company's earnings are expected to decline in the coming years, with KeyCorp forecasting FY2027 earnings at $4.55 per share and FY2028 earnings at $4.15 per share, down from the current full-year estimate of $4.71 per share. This downward trend in earnings could limit the stock's upside potential.
Nutrien Ltd. has a P/E ratio of 15.58, which is higher than the industry average, suggesting that the stock may be overvalued relative to its earnings. This could make the stock less attractive to value-oriented investors who prefer companies with lower P/E ratios.

NTR Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $81.15, with a high forecast of $100.00 and a low forecast of $65.00.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 17 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NTR shares.

According to analysts, Nutrien's stock has a predicted upside of 5.23% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 5 upgrades by analysts.

Nutrien has been rated by research analysts at Barclays, BNP Paribas Exane, Canadian Imperial Bank of Commerce, KeyCorp, Mizuho, Morgan Stanley, National Bank Financial, Oppenheimer, Royal Bank Of Canada, Scotia, Scotiabank, and Weiss Ratings in the past 90 days.

Analysts like Nutrien more than other "materials" companies. The consensus rating score for Nutrien is 2.73 while the average consensus rating score for "materials" companies is 2.57. Learn more on how NTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Nutrien Recommendations

MarketBeat monitors more than a dozen sources for Nutrien analyst ratings, with the most recent rating issued on 9/18/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Stock Forecast & Price Target